Patent · US Active

Glycan-based antibody-drug conjugates

US11332544B2 · kind B2 · utility

3Cited by

0References

4Claims

0Family size

Assignee

Merck Sharp & Dohme LLC · US

Inventors

Robert C. Davidson · Enfield, US
Bing Gong · Markham, CA

Key dates

Filing date	Apr 21, 2017
Grant date	May 17, 2022
Priority date	—
Expiry date	Jul 11, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/52
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Genetically engineered antibodies containing non-native N-glycosylated sites, preparation of the antibodies in yeast and fungi, site-specific conjugation of drugs to these antibodies, and methods of treatment utilizing these antibodies are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.